Physician Assistant · Brooklyn, NY
NPI
1407142052
Since 2011
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
210 E 2nd St
Brooklyn, NY, 11218
Phone (718) 219-7828
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.0M
39,403 prescriptions
Company payments, 2025
$11K
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Steven Kong prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 2,539 prescriptions and refills. In total Steven Kong wrote 39,403 Medicare prescriptions that cost $6.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vascepa Icosapent Ethyl | 2,539 | 2,670 | 315 | $921K |
| Atorvastatin Calcium Generic | 2,165 | 2,401 | 260 | $10K |
| Losartan Potassium Generic | 1,517 | 1,725 | 170 | $7,111 |
| Nexletol Bempedoic Acid | 1,306 | 1,529 | 175 | $604K |
| Amlodipine Besylate Generic | 1,260 | 1,402 | 138 | $4,653 |
| Donepezil Hcl Generic | 899 | 952 | 114 | $4,603 |
| Metformin Hcl Generic | 879 | 999 | 106 | $24K |
| Tamsulosin Hcl Generic | 827 | 909 | 100 | $5,899 |
| Omeprazole Generic | 728 | 755 | 136 | $4,779 |
| Meclizine Hcl Generic | 719 | 743 | 142 | $4,505 |
| Halobetasol Propionate Generic | 694 | 728 | 149 | $51K |
| Naproxen Generic | 588 | 594 | 151 | $5,262 |
| Dexlansoprazole Dr Dexlansoprazole | 587 | 676 | 101 | $101K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 578 | 630 | 60 | $4,045 |
| Gabapentin Generic | 551 | 571 | 78 | $3,597 |
Brand drugs: 9,686 claims; generic drugs: 28,873 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Kong $11K ($11K in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $7,290.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 30 | $7,290 |
| AstraZeneca Pharmaceuticals LP AZN | 26 | $949 |
| Abbvie Inc. ABBV | 12 | $484 |
| Amgen Inc. AMGN | 12 | $352 |
| Pfizer Inc. PFE | 12 | $289 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 26 | $265 |
| Madrigal Pharmaceuticals MDGL | 5 | $252 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $248 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $210 |
| Esperion Therapeutics, Inc. ESPR | 9 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.